Raule Nicola, Sevini Federica, Li Shengting, Barbieri Annalaura, Tallaro Federica, Lomartire Laura, Vianello Dario, Montesanto Alberto, Moilanen Jukka S, Bezrukov Vladyslav, Blanché Hélène, Hervonen Antti, Christensen Kaare, Deiana Luca, Gonos Efstathios S, Kirkwood Tom B L, Kristensen Peter, Leon Alberta, Pelicci Pier Giuseppe, Poulain Michel, Rea Irene M, Remacle Josè, Robine Jean Marie, Schreiber Stefan, Sikora Ewa, Eline Slagboom Peternella, Spazzafumo Liana, Antonietta Stazi Maria, Toussaint Olivier, Vaupel James W, Rose Giuseppina, Majamaa Kari, Perola Markus, Johnson Thomas E, Bolund Lars, Yang Huanming, Passarino Giuseppe, Franceschi Claudio
BioPhysics and Biocomplexity and Department of Experimental Pathology, C.I. G. Interdepartmental Centre L. Galvani for Integrated Studies on Bioinformatics, University of Bologna, Bologna, 40126, Italy.
Aging Cell. 2014 Jun;13(3):401-7. doi: 10.1111/acel.12186. Epub 2013 Dec 17.
To re-examine the correlation between mtDNA variability and longevity, we examined mtDNAs from samples obtained from over 2200 ultranonagenarians (and an equal number of controls) collected within the framework of the GEHA EU project. The samples were categorized by high-resolution classification, while about 1300 mtDNA molecules (650 ultranonagenarians and an equal number of controls) were completely sequenced. Sequences, unlike standard haplogroup analysis, made possible to evaluate for the first time the cumulative effects of specific, concomitant mtDNA mutations, including those that per se have a low, or very low, impact. In particular, the analysis of the mutations occurring in different OXPHOS complex showed a complex scenario with a different mutation burden in 90+ subjects with respect to controls. These findings suggested that mutations in subunits of the OXPHOS complex I had a beneficial effect on longevity, while the simultaneous presence of mutations in complex I and III (which also occurs in J subhaplogroups involved in LHON) and in complex I and V seemed to be detrimental, likely explaining previous contradictory results. On the whole, our study, which goes beyond haplogroup analysis, suggests that mitochondrial DNA variation does affect human longevity, but its effect is heavily influenced by the interaction between mutations concomitantly occurring on different mtDNA genes.
为了重新审视线粒体DNA(mtDNA)变异性与长寿之间的相关性,我们检测了从2200多名超级百岁老人(以及相同数量的对照)样本中获取的mtDNA,这些样本是在GEHA欧盟项目框架内收集的。样本通过高分辨率分类进行归类,同时对约1300个mtDNA分子(650名超级百岁老人和相同数量的对照)进行了全序列测定。与标准单倍群分析不同,序列测定首次使得评估特定的、伴随发生的mtDNA突变的累积效应成为可能,包括那些本身影响较小或非常小的突变。特别是,对不同氧化磷酸化(OXPHOS)复合体中发生的突变分析显示了一个复杂的情况,90岁以上的受试者与对照组相比,其突变负荷不同。这些发现表明,OXPHOS复合体I亚基中的突变对长寿有有益影响,而复合体I和III(在与Leber遗传性视神经病变相关的J单倍群中也存在)以及复合体I和V中同时存在突变似乎是有害的,这可能解释了先前相互矛盾的结果。总体而言,我们超越单倍群分析的研究表明,线粒体DNA变异确实会影响人类寿命,但其影响受到不同mtDNA基因上同时发生的突变之间相互作用的严重影响。